Arctic Bioscience AS provided earnings guidance for the fiscal year 2022. For the period, the company expects revenue to be in the range of NOK 30 million NOK 40 million.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
10.2 NOK | +3.03% | +2.00% | -2.86% |
03-01 | Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-01 | Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.86% | 23.5M | |
+37.74% | 723B | |
+34.31% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.06% | 244B | |
+9.82% | 208B | |
-4.34% | 205B | |
+2.81% | 168B |
- Stock Market
- Equities
- ABS Stock
- News Arctic Bioscience
- Arctic Bioscience Provides Earnings Guidance for the Fiscal Year 2022